Annual report [Section 13 and 15(d), not S-K Item 405]

Equity Investment (Details Narrative)

v3.25.4
Equity Investment (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Iliad [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage fully diluted 4.80%  
Equity investment net loss $ 1,603,000 $ 1,912,000
Iliad [Member] | Class C Units [Member]    
Schedule of Equity Method Investments [Line Items]    
Ownership percentage not fully diluted 6.40%  
ILiAD Biotechnologies LLC [Member]    
Schedule of Equity Method Investments [Line Items]    
Aggregrate investment $ 7,000,000 $ 7,000,000